Mundelein, IL, United States of America

Didier Lefebvre

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2003-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Didier Lefebvre

Introduction

Didier Lefebvre is an accomplished inventor based in Mundelein, IL (US). He holds a total of 4 patents that showcase his contributions to the field of pharmaceutical technology. His work primarily focuses on innovative methods for drug delivery and formulation.

Latest Patents

One of his notable patents is a "Method for producing monolithic tablets." This invention relates to a process for producing monolithic tablets using a melt-processed composition that contains at least one active agent and one thermoplastic binder. Additionally, he has developed a "Delivery system for sustained release of a calcium-channel blocking agent." This system is designed for introduction into the cerebrospinal fluid of a subject and comprises a solid dispersion product of a calcium-channel blocking agent in a specific mixture of poly(lactide-co-glycolide).

Career Highlights

Throughout his career, Didier has worked with several prominent companies, including BDS Pharma GmbH and Virginia Tech Intellectual Properties, Inc. His experience in these organizations has allowed him to refine his skills and contribute significantly to the field of pharmaceutical innovations.

Collaborations

Didier has collaborated with notable professionals in his field, including Jorg Breitenbach and Bernd Liepold. These collaborations have further enhanced his research and development efforts.

Conclusion

Didier Lefebvre's innovative work in drug delivery systems and tablet production highlights his significant contributions to pharmaceutical technology. His patents reflect a commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…